%0 Journal Article
%A Christakoudi, Sofia
%A Tsilidis, Konstantinos K
%A Dossus, Laure
%A Rinaldi, Sabina
%A Weiderpass, Elisabete
%A Antoniussen, Christian S
%A Dahm, Christina C
%A Tjønneland, Anne
%A Mellemkjær, Lene
%A Katzke, Verena
%A Kaaks, Rudolf
%A Schulze, Matthias B
%A Masala, Giovanna
%A Grioni, Sara
%A Panico, Salvatore
%A Tumino, Rosario
%A Sacerdote, Carlotta
%A May, Anne M
%A Monninkhof, Evelyn M
%A Quirós, J Ramón
%A Bonet, Catalina
%A Sánchez, Maria-Jose
%A Amiano, Pilar
%A Chirlaque, María-Dolores
%A Guevara, Marcela
%A Rosendahl, Ann H
%A Stocks, Tanja
%A Perez-Cornago, Aurora
%A Tin Tin, Sandar
%A Heath, Alicia K
%A Aglago, Elom K
%A Peruchet-Noray, Laia
%A Freisling, Heinz
%A Riboli, Elio
%T A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
%J BMC cancer
%V 23
%N 1
%@ 1471-2407
%C Heidelberg
%I Springer
%M DKFZ-2023-01215
%P 562
%D 2023
%X Associations of body shape with breast cancer risk, independent of body size, are unclear because waist and hip circumferences are correlated strongly positively with body mass index (BMI).We evaluated body shape with the allometric 'a body shape index' (ABSI) and hip index (HI), which compare waist and hip circumferences, correspondingly, among individuals with the same weight and height. We examined associations of ABSI, HI, and BMI (per one standard deviation increment) with breast cancer overall, and according to menopausal status at baseline, age at diagnosis, and oestrogen and progesterone receptor status (ER+/-PR+/-) in multivariable Cox proportional hazards models using data from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.During a mean follow-up of 14.0 years, 9011 incident breast cancers were diagnosed among 218,276 women. Although there was little evidence for association of ABSI with breast cancer overall (hazard ratio HR = 0.984; 95
%K Female
%K Humans
%K Middle Aged
%K Body Mass Index
%K Breast Neoplasms: complications
%K Risk Factors
%K Progesterone
%K Prospective Studies
%K Triple Negative Breast Neoplasms: complications
%K Postmenopause
%K Somatotypes
%K ABSI (Other)
%K Body shape (Other)
%K Breast cancer (Other)
%K Hip size (Other)
%K Obesity (Other)
%K Waist size (Other)
%K Progesterone (NLM Chemicals)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37337133
%R 10.1186/s12885-023-11056-1
%U https://inrepo02.dkfz.de/record/276938